In a prospective study of liver function following repeat anaesthesia, patients who received repeat halothane had a higher frequency of abnormal liver enzyme results than a similar group who received repeat enflurane. Obesity and short intervals between administrations increased the likelihood of abnormal liver enzyme activity in the halothane group. Enflurane would seem to be the volatile agent of choice for repeat anaesthesia in such circumstances.
Introduction
It is a decade since the results of the mammoth American National Halothane Study were published (Bunker et al. 1969) . This retrospective survey of 860000 anaesthetics revealed no conclusive evidence as to a specific hepatotoxic effect of halothane as compared with other inhalational anaesthetics (Dykes 1971 (Dykes , 1977 .
The present prospective study was undertaken to ascertain whether repeat administrations of halothane were more likely to result in detectable degrees of liver damage than other comparable agents. It also aims at identifying patients who are particularly at risk should such a hepatotoxic effect be demonstrated.
At the time of conception of the study -the acceptable alternative inhalational anaesthetics were trichloroethylene and methoxyflurane. As it later transpired that the study should be done mainly on outpatients having minor operations, these agents were clinically unacceptable as was the thiopentone-fentanyl sequence. Fortunately, enflurane was released for clinical use around 1977 and proved a satisfactory alternative to halothane (Black et al. 1977) . This made the study feasible in its present form and it evolved into a prospective comparison of the potential hepatotoxic effects of halothane and enflurane.
'Halothane hepatitis' is a very rare phenomenon and it would be virtually impossible, in terms of patient numbers, to design a prospective controlled study to detect difference in frequency of this event with two anaesthetic agents. Jaundice is the end result of greater biochemical upset, and Figure 1 shows the rationale of the study. Ethically one could not justify liver biopsy as a means of obtaining the necessary information. The frequency of enzyme changes, liver biopsy changes, jaundice and finally death decreases progressively, but in two comparable patient groups it is hoped that the relationship of the incidence of the lesser changes will parallel those of frank jaundice and even the fatal outcome (Orlandi & Marubini 1972) .
The organization of a prospective study of changes in liver enzyme levels following repeat anaesthetics is difficult and requires close cooperation with surgical and other colleagues. The large proportion of outpatients in the study made time-consuming domiciliary visits necessary and allowed less opportunity for clinical assessment of the patient than with inpatients. The fact that this study obtained reliable data over a 3-year period on only 129 patients having repeat anaesthetics emphasizes these problems .
Methods

Patients:
To avoid procedures which could affect hepatic blood flow and liver function the operations had to be minor in nature and not requiring blood transfusion. Patients had to be I Based on papers read to Section of Anaesthetics, 7 December 1979. Accepted 23 December 1980 Figure 1. Suggested relationsh!p between .the incidence of varying degrees of hver dysfunction free from sepsis, and it was important that they could be safely anaesthetized with a simple technique consisting of a thiopentone induction (4-5 mg/kg) followed by nitrous oxideoxygen supplemented by either halothane or enflurane. It was also essential that a separate machine be used for each anaesthetic agent. These r~quirements were met in patients requiring cystoscopy (or similar related operations) or women having repeated radium application to the cervix. Most of these were outpatients or only spent 1-2 days in hospital.
Over a period of two and a half years about 300 patients were admitted to the study and were allocated to one or other of the anaesthetic groups. This gave 63 patients with two or more administrations of halothane and 66 patients with two or more enflurane anaesthetics.
Liver function tests: Blood was drawn for biochemical analysis before induction of anaesthesia and on the 3rd-5th and 13th-15th postoperative days. The two postoperative samples were usually taken in the patients' homes where their general condition was noted on a specially prepared computer-compatible form.
A serum 'block analysis' of over 20 biochemical tests was carried out on each blood sample. Six enzymes -alkaline phosphatase (ALP), aspartate aminotransferase (AST), alanine aminotransferase (ALT), lactate dehydrogenase (LD), gamma glutamyl transferase (GGT) and serum cholinesterase (CHS) -were chosen specifically as indices of liver function. McIlroy et al. (1979) have fully described these and the method of analysis and statistical handling of the data. An abnormal elevation from the first preoperative level was taken as a rise of greater than three standard deviations of the method of estimation, based on several hundred repeated analyses of the same samples over the period of the study. A full 'blood picture' was also obtained on each sample and sera from several groups (with and without malignant disease) were tested for abnormal levels of antibodies.
Staff: This study, which continued over three years, required at least two and usually three full-time senior anaesthetic registrars, a graduate biochemist and a .back-up anaesthetic and laboratory staff. There was full consultation with statisticians before, during and after the end of the study. The investigation was directed by two consultant anaesthetists (JWD, GWB) who were mainly responsible for the protocol and policy decisions.
Results
Preliminary findings have been published by Johnston et al. (1979) and more detailed results by Fee et al. (1979) . Patients were anaesthetized with either halothane or enflurane as volatile agent, the same drug being given to each individual throughout the study. Although, because of early unavailability of enflurane, random allocation was not possible, these agents were studied in two groups of patients which were broadly comparable with respect to age, sex, physical characteristics and pathological conditions and also the interval between operations.
The incidence of changes in four of the enzymes is shown in Table 1 . Clearly abnormal enzyme activity occurs more frequently after repeat administrations of halothane than with enflurane.
Because of skew distribution of normal values, the average GGT levels were compared after logarithmic transformation, or the significant mean changes of actual levels were determined by the Wilcoxon matched-pairs signed-ranks test. Table 2 shows that significant alterations in the average values occurred consistently with halothane, but not with enflurane. There were no consistent changes in the eosinophil count with either drug. When abnormal enzyme activity followed one anaesthetic, in general it occurred on each subsequent occasion. This is illustrated in Table 3 , which lists cases in the order in which they occurred. Although not shown in this table, liver enzyme activity had almost invariably returned to normal before the next anaesthetic.
An important observation in Table 3 is that, of the 25 patients having abnormal GGT or ALT activity following repeated administrations of halothane, 10 (40%) were classed as obese. This is in marked contrast to the overall incidence of obesity in this series as whole (15/63, 24%) and the incidence of obese patients with no alteration in GGT or ALT (5/38, 13%). A similar finding was noted in relation to LD activity. No such relationship was found in the patients receiving enflurane.
Further evidence of the importance of obesity is given in Table 4 which gives the changes in four enzymes in obese and non-obese patients. If one considers the incidence of changes in one of more of these enzymes, the role of obesity is even more obvious. With halothane, 7 of IS (48%) 0 bese patients had some enzymatic evidence of liver dysfunction compared with 5 of 48 (10;',) non-obese patients. Only 7% of obese and 12% of non-obese patients had corresponding changes after enflurane. The 'obese/halothane' group is the only one which differs statistically (P < 0.0 I) from the rest of the series.
The influence of other factors which could possibly modify the effects of anaesthetics on the liver -history of jaundice, neoplasia, radiotherapy, previous blood transfusions -was examined with no positive correlation in either series. Concurrent or prior drug therapy or previous anaesthetic history was not shown to influence abnormal enzyme activity, neither did alcohol intake. However, it was found that smokers had more alterations in LD activity after a second halothane anaesthetic than non-smokers. Contrary to expectations, those few patients showing slightly elevated enzymes prior to the first anaesthetic were not found to be more likely to develop further changes than other subjects. Although the number of positive enzyme changes was too small to do a detailed survey of the importance of the interval between administrations, six weeks would appear to be a critical time. On the second administration, 50% of the halothane patients having an interval of 1-6 weeks between anaesthetics showed abnormal GGT results, compared with 23% of those in whom the interval was 7-30 weeks. A similar relationship was found with AL T and also the enflurane series (Table 5 ).
Discussion
It is difficult to ascertain the clinical implications of disordered liver function tests, but it seems reasonable to assume that the changes in serum enzyme levels found in the present study indicate some degree of hepatic damage.
In two prospective studies carried out by Wright et al. (1975) and by Trowell et al. (1975) , confined largely to women with carcinoma of the uterus requiring repeated anaesthesia for radium insertions, serum aspartate and alanine transaminase determinations were found to be elevated in those patients receiving halothane but not in the non-halothane groups. Unfortunately, when their work was being carried out, trichloroethylene and methoxyflurane were the only alternative inhalational agents available.
By contrast, in a recent prospective study of hepatocellular function after repeated exposure to halothane or enflurane in 99 negro women requiring radiation for cervical carcinoma, Allen & Downing (1977) noted that changes in serum transaminase concentrations were minimal and they concluded, at least for this procedure, in their patient population, that halothane and enflurane were equally safe.
Nevertheless, the present investigation does confirm that a substantial number of patients undergoing minor surgical procedures who receive halothane repeatedly within a short period of time develop abnormal liver function tests and that this trend becomes more pronounced as the number of administrations increases.
In the present study there was no evidence of a relationship between immunological changes and either the repeated administration of halothane or changes in enzyme levels.
Halothane is metabolized in the liver by both oxidative and reductive pathways, the latter being more potentially hepatotoxic (Cousins 1980) . Considerable increases in reductive metabolites have been demonstrated In both animal model and clinical studies in association with marked elevation of AL T levels and centrilobular hepatic necrosis (Cousins et al. 1979) .
Their work, and that of Sharp et al. (1979) , strongly suggests that a metabolite of halothane can cause direct cellular injury to the liver and could well explain the elevated serum enzyme levels observed in our study.
A significantly greater incidence of disordered liver function occurred in these subjects, and it is of interest that clinical reports by Moult & Sherlock (1975) and by Walton and his colleagues (1976) refer to a high incidence of jaundice in fat patients. Obesity may tend to cause accumulation of halothane and its metabolites in the body and the liver may be unable to deal with these when halothane is given repeatedly at short intervals.
Disturbances of hepatic function occurred less frequently following repeated administration of enflurane, and extensive animal and clinical research has failed to detect any significant alteration in liver function following exposure to this agent. In a recent study, Stacey et al. (1978) compared the toxicity of halogenated anaesthetics by incubating suspensions of rat hepatocytes with varying concentrations of the different agents. Toxicity, as determined by leakage of intracellular potassium and alanine aminotransferase, was most pronounced with chloroform and methoxyflurane, and significantly exceeded that of halothane after 20 minutes of incubation. Enflurane, however, did not affect potassium or analine aminotransferase release, even after 60 minutes of incubation, at which time halothane toxicity was markedly increased.
In our study deterioration of liver function following repeated enflurane anaesthesia did not occur more frequently in the obese than in the non-obese patient, due perhaps to its lower fat solubility and minimal storage in the body.
To conclude, it seems probable that halothane exerts a hepatotoxic action and causes some degree of liver damage with each administration. In susceptible individuals with a propensity to increased metabolism, for genetic or other reasons, clinical liver damage with jaundice may occur. However, halothane is an exceedingly useful, safe and well-tried inhalational anaesthetic and 'halothane hepatitis' is uncommon (Brown 1979) .
Our findings would point to an increased susceptibility to disordered liver function in the obese patients, particularly when the interval between halothane administrations is less than six weeks. Enflurane would appear to be the volatile agent of choice in these circumstances.
